Check how to monitor brodalumab blood levels in psoriasis
Part of Skin clinical trials.
This study measures brodalumab levels in your blood to see whether “therapeutic drug monitoring” can guide treatment in people with plaque psoriasis. If you’re eligible, it may help doctors better match the medicine to your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of chronic plaque psoriasis
- You agree to understand the study and sign an informed consent form
- Your psoriasis is mainly plaque-type, not a different main type
- You are not pregnant, breastfeeding, or planning pregnancy
- You can and are willing to have multiple blood draws (venipunctures)
- You are not taking brodalumab on a different-than-standard dosing schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a proactive approach (adjusting drug levels based on regular blood tests) versus the usual way of using biologics for psoriasis. It helps see if active monitoring can improve treatment while keeping you safe.
This trial tests a new systemic therapy for severe plaque psoriasis and uses skin imaging (dermoscopy) to track improvements. It aims to see how well the treatment works and how it affects your quality of life.
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
This study keeps track of how people with moderate-to-severe psoriasis do over time while using Siliq or other approved treatments. It may help researchers understand how treatments compare in real life.
This study looks at how blood sugar control (including diabetes) changes immune cells in the skin for people with moderate to severe plaque psoriasis. It may help researchers understand what drives psoriasis and how it could respond to future treatments.
This study uses a special ultrasound technique to get a better measure of how severe your plaque psoriasis is. It aims to see if this imaging can help doctors track the disease more accurately.
Hear when a new Psoriasis Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.